Slides
Page 1
NASDAQ: INBS | August 2026 Pioneering Pain-free Solutions Transforming drug testing with non-invasive, cost-effective, reliable solutions.
Page 2
2 Forward Looking Statements Certain statements in this presentation may constitute “forward-looking statements” as defined in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”), the Private Securities Litigation Reform Act of 1995 (the “PSLRA”), or in releases made by the U.S. Securities and Exchange Commission (the “SEC”), each as amended from time to time. Such forward-looking statements involve known and unknown risks, uncertainties, and other important factors that could cause the actual results, performance, or achievements of Intelligent Bio Solutions, Inc. and its affiliates (“INBS” or the “Company”), or industry results, to differ materially from any future results, performance, or achievements expressed or implied by such forward-looking statements. Statements that are not historical facts are forward-looking statements. Forward-looking statements can be identified by, among other things, the use of forward-looking language, such as “plan,” “believe,” “expect,” “anticipate,” “intend,” “estimate,” “project,” “potential,” “may,” “might,” “will,” “would,” “could,” “should,” “seeks,” or “scheduled to,” and similar expressions, or the negative of these terms or comparable language, as well as by discussions of strategy or intentions. Forward-looking statements in this presentation include, without limitation, statements regarding the Company’s ability to successfully develop and commercialize its testing solutions, realize commercial benefits from its partnerships and collaborations, and ability to secure regulatory clearance or approvals, among others. These cautionary statements are being made pursuant to the Securities Act, the Exchange Act, and the PSLRA, with the intention of obtaining the benefits of the “safe harbor” provisions of those laws. INBS cautions that any forward-looking statements made by INBS are not guarantees of future performance. Although INBS believes that its plans, cost estimates, returns on investments, intentions, and expectations reflected in or suggested by such forward-looking statements are reasonable, actual results could differ materially from any projections or assumptions expressed as of the date such forward-looking statements are made. INBS’s future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, including those described in INBS’s filings with the SEC. INBS does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, subsequent events, or otherwise, except as required by law. These materials are not intended as an offer to sell or a solicitation of an offer to buy any security and may not be reproduced or redistributed, in whole or in part, to any other person. Recipients should seek appropriate independent professional advice before relying on these materials or entering into any commitment based upon them. All information included in this presentation is based on continuing operations unless otherwise noted. NASDAQ: INBS